People · Operator

Takehito Jimbo

Named in public records as an officer, director or promoter · active 2009–2011 · Other Technology, Other Health Care

2
Companies
2
Filings
$15.5M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Altasens, Inc.Other TechnologySeries B$15.1M$459.9M2011
Bioabsorbable Therapeutics IncOther Health CarePre-Seed$360K$11.1M2009
Operator network

Takehito Jimbo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Akio Yoshioka · 1 companies · 1 sharedAkio YoshiokaClint Elsemore · 1 companies · 1 sharedClint ElsemoreLester Kozlowski · 1 companies · 1 sharedLester KozlowskiMasao Kuribayashi · 1 companies · 1 sharedMasao KuribayashiNaoki Yamamoto · 1 companies · 1 sharedNaoki YamamotoNubuyuki Koyama · 1 companies · 1 sharedNubuyuki KoyamaPatrick Rivelli · 6 companies · 1 sharedPatrick RivelliMichael Henson · 5 companies · 1 sharedMichael HensonAllan Johnston · 3 companies · 1 sharedAllan JohnstonBruce J Brumfield · 3 companies · 1 sharedBruce J BrumfieldGregory S. Young · 3 companies · 1 sharedGregory S. YoungMaurice Buchbinder · 3 companies · 1 sharedMaurice BuchbinderAlec Piplani · 1 companies · 1 sharedAlec PiplaniAltasens, Inc. · $15.1M raisedAltasens, Inc.Bioabsorbable Therapeutics Inc · $0.4M raisedBioabsorbable Therape…Takehito JimboTJ
Takehito Jimbo Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Takehito Jimbo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Patrick Rivelli16
Michael Henson15
Bruce J Brumfield13
Allan Johnston13
Gregory S. Young13
Maurice Buchbinder13
Akio Yoshioka11
Alec Piplani11
Clint Elsemore11
Naoki Yamamoto11
Masao Kuribayashi11
Nubuyuki Koyama11
Lester Kozlowski11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.